QQ客服 官方微博 反馈留言

浏览/检索结果: 共8条，第1-8条 帮助 限定条件 专题：中南大学    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Effect of Anlotinib as a Third-Line or Further Treatment on Overall Survival of Patients With Advanced Non-Small Cell Lung Cancer: The ALTER 0303 Phase 3 Randomized Clinical Trial. 期刊论文 JAMA Oncology, 2018, 卷号: 4, 期号: 11, 页码: 1569-1575 作者:  Han, Baohui*;  Li, Kai*;  Wang, Qiming;  Zhang, Li;  Shi, Jianhua 收藏  |  浏览/下载：7/0  |  提交时间：2019/12/03 anlotinib  non-small-cell lung carcinoma   Anlotinib as a third-line therapy in patients with refractory advanced non-small-cell lung cancer: a multicentre, randomised phase II trial (ALTER0302) 期刊论文 British Journal of Cancer, 2018, 卷号: 118, 期号: 5, 页码: 654-661 作者:  Han, Baohui*;  Li, Kai;  Zhao, Yizhuo;  Li, Baolan;  Cheng, Ying 收藏  |  浏览/下载：9/0  |  提交时间：2019/12/03 non-small-cell lung cancer  multitarget  tyrosine kinase inhibitor  anlotinib  third line   China experts consensus on the diagnosis and treatment of advanced stage primary lung cancer (2016 version) 期刊论文 Asia‐Pacific Journal of Clinical Oncology, 2017, 卷号: 13, 期号: 1, 页码: 87-103 作者:  Shi, Yuankai*;  Sun, Yan;  Yu, Jinming;  Ding, Cuimin;  Wang, Ziping 收藏  |  浏览/下载：8/0  |  提交时间：2019/12/03 Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China 期刊论文 Journal of Hematology & Oncology, 2017, 卷号: 10, 期号: 1, 页码: 69- 作者:  Shi, Yuankai*;  Jia, Bo;  Xu, Wei;  Li, Wenyu;  Liu, Ting 收藏  |  浏览/下载：10/0  |  提交时间：2019/12/03 Chemotherapy  Chidamide  Peripheral T cell lymphoma  Treatment   Piezo-phototronic Effect Enhanced Responsivity of Photon Sensor Based on Composition-Tunable Ternary CdSxSe1-x Nanowires 期刊论文 ACS Photonics, 2017, 卷号: 4, 期号: 10, 页码: 2495-2503 作者:  Dai, Guozhang;  Zou, Haiyang;  Wang, Xingfu;  Zhou, Yuankai;  Wang, Peihong 收藏  |  浏览/下载：6/0  |  提交时间：2019/12/03 CdSxSe1-x  nanowire  photodetector  piezo-phototronic effect   Platinum‐based chemotherapy plus cetuximab first‐line for Asian patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: Results of an open‐label, single‐arm, multicenter trial 期刊论文 Head & Neck, 2015, 卷号: 37, 期号: 8, 页码: 1081-1087 作者:  Guo, Ye;  Shi, Mei;  Yang, Ankui;  Feng, Jifeng;  Zhu, Xiaodong 收藏  |  浏览/下载：9/0  |  提交时间：2019/12/03 cetuximab  Chinese  EXTREME trial  head and neck cancer  recurrent and metastatic squamous cell carcinoma   Current small cell lung cancer treatment in China 期刊论文 Thoracic Cancer, 2015, 卷号: 6, 期号: 3, 页码: 233-238 作者:  Shi, Yuankai*;  Xing, Puyuan;  Fan, Yun;  Zhang, Xin;  Hu, Chengping 收藏  |  浏览/下载：4/0  |  提交时间：2019/12/03 Chemotherapy  Chinese population  epidemiology  radiotherapy  small cell lung cancer   Icotinib versus gefitinib in previously treated advanced non-small-cell lung cancer (ICOGEN): a randomised, double-blind phase 3 non-inferiority trial 期刊论文 The Lancet Oncology, 2013, 卷号: 14, 期号: 10, 页码: 953-961 作者:  Shi, Yuankai*;  Zhang, Li;  Liu, Xiaoqing;  Zhou, Caicun;  Zhang, Shucai 收藏  |  浏览/下载：10/0  |  提交时间：2019/12/03